Quest Diagnostics Incorporated
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Quest Diagnostics Incorporated
With COVID-19 a residual but still very real issue globally, Novo Holdings asked the big diagnostics question at a recent high-level roundtable: How can stakeholders capitalize on this moment of acute public awareness of diagnostics to improve adoption of tests and screening in the long term? The CEOs of Roche Diagnostics, GE Healthcare, Labcorp and Synlab, among others, gave their thoughts on how the system must change.
Oncology diagnoses and therefore revenues are returning as we emerge from the pandemic, but the recovery also brings the challenges of reduced diagnostic and eventually vaccine revenues.
Quest signed an agreement with Paige to develop regulatory-approved software and services to be marketed to expand digital pathology network for pathologists.
Private Company Edition: Perceptive/Xontogeny, Abingworth, Kizoo and Droia closed venture capital funds. New biopharma VC financings also include a $105m series C round for Elpiscience and $92m for newly launched Interline.
- Diagnostic Imaging Services
- Other Names / Subsidiaries
- ADI Holding Company
- Athena Diagnostics
- Blueprint Genetics
- Boyce and Bynum Pathology Laboratories
- California Laboratory Associates (CLA)
- Celera Group
- Cleveland HeartLab Inc.
- Hurley Medical Center
- Pathway Diagnostics
- Shiel Medical Laboratory
- Solstas Lab Partners
- Summit Health
- Superior Mobile Medics
- Mid America Clinical Laboratories (MACL)